未找到相关数据
First-in-human, dose escalation and expansion study of MT-6402, a novel engineered toxin body (ETB) targeting PD-L1, in patients with PD-L1 expressing relapsed/refractory advanced solid tumors: Interim data
被引：0
作者：
Van Tine, Brian A.
Ahn, Eugene
Redman, Rebecca A.
Barve, Minal A.
Edenfield, William J.
Peguero, Julio
Villaflor, Victoria M.
Rasco, Drew W.
Powell, Steven F.
Mamuye, Admasu T.
Moore, Chris B.
Pelham, Joshua M.
Charoenthongtrakul, Soratree
Spigel, David R.
机构：
关键词：
D O I：
10.1158/1538-7445.AM2024-CT191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT191
引用
收藏
页数：2
相关论文